EmergingMed's mission is to create a coordinated, seamless connection between patients, clinical trials, and physicians at exactly the right time--when a person's medical situation is perfectly aligned with a researcher's effort to find new and better treatments. The company?s broader vision is to accelerate the discovery of new and better treatments for people with serious and life threatening medical conditions.
Our commitment to privacy and security is uncompromising and guides
every decision we make. All information submitted to EmergingMed is
password protected, confidential and secure. We will never sell
or share your personal information. See our
Our Patented Clinical Trial Matching Service
EmergingMed offers a patented (US Patent No. 7,711,580 B2) clinical trial matching service that helps people, in a matter of minutes,
find appropriate clinical trials and trial sites that match their specific diagnosis, stage, symptoms, and treatment history.
EmergingMed was founded in January 2000 after months of interviews with patients, advocates, caregivers and researchers who helped us
understand the barriers, misperceptions, and logistical challenges associated with finding relevant clinical trials and making informed
treatment decisions. The EmergingMed.com website was launched in October 2000.
As we celebrate our 10th anniversary, EmergingMed's management team has proven that it is
adept at innovating as well as delivering solutions to help bring new therapies to market
while empowering patients to make more informed treatment decisions.
Our Medical Advisory Board
EmergingMed works closely with distinguished physicians and clinical researchers who help our staff bring unbiased, comprehensive
clinical trial information to the public.
The following is a list of our oncology advisory board members:
Our Collaborations with Patient Advocacy Organizations
EmergingMed works closely with patient advocates and advocacy groups who have direct experience with clinical trials or who want to
increase awareness of, education about and access to clinical trials.
How We Get Paid
EmergingMed's clinical trial matching, referral, and navigation services are provided free of charge to patients and physicians searching for
clinical trials. EmergingMed receives monthly subscription fees for providing phone-based and/or web-based clinical trial information services
for many organizations including patient advocacy groups, pharmaceutical and biotechnology companies, medical centers and groups of health care
providers. EmergingMed is never paid for enrolling a patient in a trial.
EmergingMed is a private company owned and operated by Final Four Health Solutions, LLC with headquarters at 2605 Meridian Parkway, Durham, NC 27713.
EmergingMed has chosen not to accept investments from pharmaceutical or biotechnology companies to ensure that our services remain unbiased.
Letter from the CEO
Late one Sunday evening In January 1999, my husband called me on his cell phone from a taxi. He was seriously ill and on his way to the hospital.
The doctors were able to stabilize him temporarily, but they recommended additional surgery. My husband refused to undergo what would be a long,
difficult operation that would require months of recovery. I was obviously upset - not only about my husband's condition, but also about his apparent
unwillingness to accept the recommended treatment.
I was torn between the competing desires to respect his choices and to convince him to get treatment immediately. I began to search for treatment
options, mainly through the Internet, but found the information presented too simplistic, too scientific, or too voluminous. By chance, a friend
in California sent my husband an article about an alternative surgery at another hospital that had only recently been developed. This surgery was
being performed only a few miles from our home in New York City, yet we had never heard about it. My husband underwent this surgery, and eleven years
later is still doing fine.
EmergingMed created its clinical trial matching and referral system to quickly connect patients to appropriate clinical trial options. We added educational services and follow-up support to help families make sense of these options and to successfully navigate the health care system.
No family should ever have to ask: "Why didn't anyone tell us?"
CEO and Founder, EmergingMed